Pfizer's Zoloft and recently launched Xanax XR provide the "complete solution for patients across a number of anxiety positions," Pfizer President Global Pharmaceuticals Karen Katen said during an analyst meeting in New York June 17

Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.

To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.